This is a review about Ccne2, based on 13 published articles (read how Labome selects the articles), using Ccne2 antibody in all methods. It is aimed to help Labome visitors find the most suited Ccne2 antibody.
Santa Cruz Biotechnology
rabbit polyclonal (H-140)
  • WB; human; 1:200
Santa Cruz Biotechnology Ccne2 antibody (Santa Cruz Biotechnology, sc-22777) was used in western blot on human samples at 1:200. Biochim Biophys Acta (2014) ncbi
Epitomics
not indicated
  • WB; mouse
  • IP; mouse
Epitomics anti-cyclin E2 antibody was used to carry out western blot analysis and immunoprecipitation assays in order to investigate the role of the CDP/Cux processed isoform p110 in cell cycle progression.Mol Cell Biol (2006) ncbi
Cell Signaling Technology
mouse monoclonal (HE12)
  • WB; human; fig 4c
In order to report that expression of HIF2alpha is regulated by the deubiquitylase Cezanne in an E2F1-dependent manner, Cell Signaling Technology Ccne2 antibody (Cell Signaling, HE12) was used in western blot on human samples (fig 4c). J Cell Sci (2015) ncbi
mouse monoclonal (HE12)
  • WB; human; 1:750; fig 2
In order to investigate the contribution of cyclobutane pyrimidine dimers to UVB-induced changes of gene expression, Cell Signaling Technology Ccne2 antibody (Cell Signaling, 4129) was used in western blot on human samples at 1:750 (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (HE12)
  • WB; human; 1:60000
Cell Signaling Technology Ccne2 antibody (Cell Signaling, 4129) was used in western blot on human samples at 1:60000. Oncotarget (2015) ncbi
mouse monoclonal (HE12)
  • WB; human; 1:500
Cell Signaling Technology Ccne2 antibody (Cell Signaling Technology, 4129S) was used in western blot on human samples at 1:500. Br J Pharmacol (2015) ncbi
mouse monoclonal (HE12)
  • WB; human
In order to study CREB in acute myeloid leukemia, Cell Signaling Technology Ccne2 antibody (Cell Signaling, HE12) was used in western blot on human samples. Leukemia (2015) ncbi
mouse monoclonal (HE12)
  • WB; human; fig 6e
Cell Signaling Technology Ccne2 antibody (Cell Signaling Technologies, 4129) was used in western blot on human samples (fig 6e). Mol Cell (2014) ncbi
mouse monoclonal (HE12)
  • WB; human
Cell Signaling Technology Ccne2 antibody (Cell Signaling, 4129) was used in western blot on human samples. J Natl Cancer Inst (2014) ncbi
mouse monoclonal (HE12)
  • WB; human
In order to evaluate large subunit ribosomal proteins as therapeutic targets for melanoma, Cell Signaling Technology Ccne2 antibody (Cell Signaling, 4129) was used in western blot on human samples. Pigment Cell Melanoma Res (2014) ncbi
mouse monoclonal (HE12)
  • WB; human
In order to study the involvement of RASSF1A inactivation in carcinogenesis, Cell Signaling Technology Ccne2 antibody (Cell Signaling Technology, 4129) was used in western blot on human samples. Mol Cell Biol (2014) ncbi
mouse monoclonal (HE12)
  • WB; human
Cell Signaling Technology Ccne2 antibody (Cell Signaling Technology, 4129) was used in western blot on human samples. Cell Signal (2014) ncbi
mouse monoclonal (HE12)
  • WB; human; 1:3000
Cell Signaling Technology Ccne2 antibody (Cell Signaling, 4129) was used in western blot on human samples at 1:3000. Exp Hematol (2012) ncbi
Articles Reviewed
  1. Sónia Moniz et al. (2015). "Cezanne regulates E2F1-dependent HIF2α expression".PMID 26148512
  2. Gábor Boros et al. (2015). "Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA".PMID 26121660
  3. Seiichiro Ishihara et al. (2015). "Activating transcription factor 5 enhances radioresistance and malignancy in cancer cells".PMID 25682872
  4. Marina Barrichon et al. (2015). "Dose-dependent biphasic leptin-induced proliferation is caused by non-specific IL-6/NF-κB pathway activation in human myometrial cells".PMID 25653112
  5. H D Chae et al. (2015). "Replication factor C3 is a CREB target gene that regulates cell cycle progression through the modulation of chromatin loading of PCNA".PMID 25541153
  6. Jessica A Gasser et al. (2014). "SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer".PMID 25458846
  7. Weimin Qiu et al. (2014). "miR-141-3p inhibits human stromal (mesenchymal) stem cell proliferation and differentiation".PMID 24937190
  8. Iraz T Aydin et al. (2014). "FBXW7 mutations in melanoma and a new therapeutic paradigm".PMID 24838835
  9. Gregory R Kardos et al. (2014). "Growth inhibitory effects of large subunit ribosomal proteins in melanoma".PMID 24807543
  10. Rosalyn R Ram et al. (2014). "RASSF1A inactivation unleashes a tumor suppressor/oncogene cascade with context-dependent consequences on cell cycle progression".PMID 24732797
  11. Suman Sengupta et al. (2014). "TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells".PMID 24269534
  12. Benigno C Valdez et al. (2012). "Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines".PMID 22687754
  13. Laurent Sansregret et al. (2006). "The p110 isoform of the CDP/Cux transcription factor accelerates entry into S phase".PMID 16508018